Sacral Nerve Stimulation Market is Anticipated to Witness High Growth Owing to Rising Geriatric Population

 

Global Sacral Nerve Stimulation Market

Global sacral nerve stimulation is a minimally invasive treatment method that involves the use of an implantable medical device to deliver mild electrical pulses to sacral nerves in order to manage bladder, bowel and sexual dysfunction. Sacral nerve stimulation devices include tined leads, implantable pulse generators and external trial stimulators. These devices help modulate neural pathways in the sacral nerve and ultimately treat voiding dysfunction, fecal incontinence and pelvic pain. The growing geriatric population suffering from neurological and urological disorders has been a major factor driving the adoption of sacral nerve stimulation therapy.

The global sacral nerve stimulation market is estimated to be valued at US$ 422.7 Mn in 2024 and is expected to exhibit a CAGR of 6.0% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Sacral Nerve Stimulation Market Demand are Medtronic plc., Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc., Synapse Biomedical, Uroplasty, St. Jude Medical, Cogentix Medical. Sacral nerve stimulation offers minimally invasive treatment options for patients who fail to respond to conventional therapies such as biofeedback, pelvic floor exercises or medication. The aging population worldwide and growing healthcare expenditure in emerging economies create significant opportunities for players in this market. Major companies are focusing on new product innovations, geographic expansion and acquisitions to strengthen their market position.

Market Drivers

Rising Geriatric Population: The elderly population is more prone to experience urinary incontinence, bowel dysfunction and pelvic floor disorders due to weakening muscles and nerves over time. According to the United Nations, the number of people aged 60 years and older is expected to more than double by 2050. This growing geriatric demographic will augment the demand for sacral nerve stimulation therapy.

Market Restrains

High Cost of Devices: Sacral nerve stimulation devices involve significant capital expenditure for implantable pulse generators, leads and surgical procedures. While effective in managing voiding dysfunctions, the high upfront costs pose affordability challenges. This can negatively impact market growth, especially in price-sensitive developing countries.


Segment Analysis

The global sacral nerve stimulation market is segmented on the basis of implantable & non-implantable devices and application. Implantable devices sub segment dominates the market owing to its advantages over non-implantable devices. Implantable devices offer continuous stimulation over long term period which provides effective treatment for urinary & fecal incontinence.

Under application segmentation, the urinary incontinence indication holds the highest market share. Urinary incontinence is the most common type of incontinence and needs immediate medical help. It has significant impact on quality of life. Thus, sacral nerve stimulation provides effective therapy for treating urinary incontinence and remains the dominating sub segment.

Global Analysis

North America accounts for the largest share in the global sacral nerve stimulation market due to robust reimbursement structure and high healthcare spending. Presence of major players and adoption of innovative technologies further supports market growth. Europe stands as the second largest market for sacral nerve stimulationdevices. Asia Pacific shows highest growth rate owing to rising healthcare expenditures, increasing patient awareness and improving accessibility to advanced medical services. Growing geriatric population vulnerable to incontinence drives the regional market growth over the forecast period.

Get more insights on Global Sacral Nerve Stimulation Market

Comments

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Automation of Agricultural Operations to Drive the Agricultural Drones Market Growth